©The Author(s) 2016.
World J Gastroenterol. Sep 14, 2016; 22(34): 7625-7644
Published online Sep 14, 2016. doi: 10.3748/wjg.v22.i34.7625
Published online Sep 14, 2016. doi: 10.3748/wjg.v22.i34.7625
Table 8 Preventive health measures in inflammatory bowel disease
| Morbidity | Preventive measures | Setting | Provider |
| Venous thromboembolism | |||
| Dehydration | Encourage adequate hydration | Out-patient | PCP1, Hospitalist1 |
| Intravenous fluids when indicated | In-patient | Gastroenterologist2 | |
| Prolonged immobilization | Encourage physical activity | Out-patient | PCP1 |
| Early ambulation during hospitalization | In-patient | Hospitalist1 | |
| Indwelling catheters | Limit use of venous catheters when possible | In-patient | Hospitalist1, Gastroenterologist2 |
| Hyperhomocysteinemia | Detection and correction of vitamin deficiencies B6, B12, folate | Out-patient | PCP1 |
| Gastroenterologist2 | |||
| Oral contraceptives | Advise on alternative methods of contraception | Out-patient | PCP1 |
| Active intestinal disease | Anti-inflammatory treatment, monitoring of medication and response to therapy. | Out-patient | Gastroenterologist1 |
| (inflammatory burden) | PCP2 | ||
| Cardiovascular disease | |||
| Hypertension (Primary and secondary prevention) | Low sodium diet, smoking cessation, increased physical activity. | Out-patient | PCP1 |
| Anti-hypertensive medication | |||
| Coronary artery disease | Low sodium diet, smoking cessation, increased physical activity, screening for hyperlipidemia. Statins, anti-platelet drugs, | Out-patient | PCP1 |
| (Primary and secondary prevention) | Cardiologist1, Gastroenterologist2 | ||
| Stroke | Anti-platelet therapy, statins, Anti-hypertensive medications | Out-patient | PCP1, Neurologist2 Gastroenterologist2 |
| (Primary and secondary prevention) | |||
| Smoking | |||
| Smoking cessation advise, nicotine replacement therapy, smoking cessation counselling and support programs | Out-patient | PCP1 | |
| Gastroenterologist2 | |||
| Cancer | |||
| Skin | Advise on UV exposure | Outpatient | PCP1 |
| Protective clothing , high SPF sunscreen | Gastroenterologist2 | ||
| Yearly physician skin exam | |||
| Colon | Surveillance colonoscopy per IBD guidelines | Out-patient | Gastroenterologist1 |
| PCP2 | |||
| Cervical | PAP smear | Out-patient | Gynecologist1, PCP2 |
| Breast | Counselling on breast cancer awareness | Out-patient | PCP1 |
| CBE every 3 yr | |||
| Mammography after 40 yr | |||
| Prostate | Counseling and Shared-decision making on PSA testing | Out-patient | PCP1 |
| Nutritional deficiencies | Screen for and correct nutritional deficiencies | Out-patient | PCP1 |
| Gastroenterologist2 | |||
| Osteoporosis | DEXA in patients with increased risk of osteoporosis (hx of steroid use 10 mg daily x > 3 mo) treatment with bisphosphonates if osteoporosis confirmed. | Out-patient | PCP1 |
| Gastroenterologist2 | |||
| Infections | |||
| Vaccine preventable infections | Vaccination | Out-patient | PCP1 |
| Gastroenterologist2 | |||
| Reactivation of Hepatitis B virus | Screening for HBV before initiating | Out-patient | Gastroenterologist1 |
| Anti-TNF therapy | |||
| Reactivation of latent Tuberculosis | Screening for latent TB before initiating | Out-patient | Gastroenterologist1 |
| Anti-TNF therapy | |||
| Anemia | Detection and treatment of anemia | Out-patient | PCP1 |
| Gastroenterologist2 | |||
| Depression | Depression screening PHQ 2 | Out-patient | PCP1 |
| if positive do PHQ 9 for diagnosis | Gastroenterologist2 | ||
| Mild depression -counselling | |||
| Moderate to severe- counselling +medication | |||
| Sleep disturbance | Screening for sleep disturbance, Counseling on sleep hygiene | Out-patient | PCP1 |
| Gastroenterologist2 | |||
| Medical therapy | |||
| Medication related adverse effects | Assessing medication adverse effects and interactions | Out-patient | Gastroenterologist1 |
| PCP2 | |||
| Medication Non-adherence | Screening for medication non-adherence | Out-patient | Gastroenterologist1 |
| MMAS-8 item questionnaire | PCP2 | ||
| Review frequency of medication refills | |||
| Drug levels for anti-TNF and thiopurines | |||
- Citation: Abegunde AT, Muhammad BH, Ali T. Preventive health measures in inflammatory bowel disease. World J Gastroenterol 2016; 22(34): 7625-7644
- URL: https://www.wjgnet.com/1007-9327/full/v22/i34/7625.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i34.7625